Sarah A. Frech

Corporate Officer/Principal at IOMAI CORPORATION

Consumer Services

Health Technology

Profile

Dr. Sarah A. Frech is Vice President-Clinical Development at Intercell USA, Inc. and Vice President-Clinical Research at Vtesse, Inc. She received her undergraduate degree from Dartmouth College, a graduate degree from the Johns Hopkins Bloomberg School of Public Health, and a doctorate degree from Washington State University.

Sarah A. Frech active positions

Companies	Position	Start
IOMAI CORPORATION	Corporate Officer/Principal	-

All active positions of Sarah A. Frech

Former positions of Sarah A. Frech

Companies	Position	End
Vtesse, Inc. Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases	Corporate Officer/Principal	-

See the detail of Sarah A. Frech's experience

Training of Sarah A. Frech

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sarah A. Frech's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Dartmouth College Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Washington State University Washington State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Intercell USA, Inc. Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants	Health Technology
Johns Hopkins Bloomberg School of Public Health Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vtesse, Inc. Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases	Health Technology